Technologies for the identification of osteoporosis
Amicosante AMV, Bernardini F, Cavallo A, Cerbo M, Jefferson T, Lo Scalzo A, Ratti M
Record ID 32013000645
Authors' objectives: The objectives of this report are: to identify the most widely used technologies for the identification and assessment of osteoporosis in the target population in our country; to accurately describe the acquisition and use of the technology and its alternative in the Italian context; to assess the evidence for the chosen technologies, to perform a cost-effectiveness analysis comparing DEXA with the most widely used alternatives used in the target population.
Authors' recommendations: DEXA is the most used device at outpatient level for the identification of osteoporosis in our target population and has a higher imaging efficacy when compared with QUS (its most likely competitor in 14 Italian regions). We identified 7 studies comparing DEXA with QUS in postmenopausal women. We did not carry out a meta-analysis. When using basic DEXA and QUS equipment, our economic evaluation based on over 12 and a half million women shows that DEXA is the dominant procedure for identifying osteoporosis in a general population of postmenopusal women (incremental cost effectiveness ratio €1,095). DEXA is the dominant technology. Should improvements arise, this report should be updated.
Project Status: Completed
Year Published: 2009
URL for published report: http://www.salute.gov.it/imgs/C_17_pagineAree_1202_listaFile_itemName_7_file.pdf
English language abstract: An English language summary is available
Publication Type: Not Assigned
- Bone Density
Organisation Name: The Italian National Agency for Regional Health Services (Agenas)
Contact Address: Agenzia nazionale per i servizi sanitari regionali, Via Puglie 23, 00187 Rome, Italy
Contact Name: firstname.lastname@example.org
Contact Email: email@example.com
Copyright: Italian Ministry of Health and Agenas
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.